These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25700703)

  • 1. Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer.
    Bernstein JM; Kershaw LE; Withey SB; Lowe NM; Homer JJ; Slevin NJ; Bonington SC; Carrington BM; West CM
    Oral Oncol; 2015 May; 51(5):508-13. PubMed ID: 25700703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy.
    Lowe NM; Kershaw LE; Bernstein JM; Withey SB; Mais K; Homer JJ; Slevin NJ; Bonington SC; Carrington BM; West CM
    PLoS One; 2018; 13(3):e0194841. PubMed ID: 29590180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis.
    Elicin O; Schmucking M; Bromme J; Rauch D; Ambarcioglu P; Plasswilm L; Geretschlager A; Ghadjar P; Giger R; Aebersold DM
    J BUON; 2016; 21(1):175-81. PubMed ID: 27061546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
    Guo W; Zhang Y; Luo D; Yuan H
    Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
    [No Abstract]   [Full Text] [Related]  

  • 6. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI.
    Fujima N; Yoshida D; Sakashita T; Homma A; Tsukahara A; Tha KK; Kudo K; Shirato H
    Magn Reson Imaging; 2014 Dec; 32(10):1206-13. PubMed ID: 25131628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters.
    Craciunescu OI; Yoo DS; Cleland E; Muradyan N; Carroll MD; MacFall JR; Barboriak DP; Brizel DM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e345-50. PubMed ID: 21985945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Histogram Analysis DCE MRI Parameters and Complex
    Surov A; Leifels L; Meyer HJ; Winter K; Sabri O; Purz S
    Anticancer Res; 2018 Mar; 38(3):1637-1642. PubMed ID: 29491096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.
    Abdel Razek AAK; Nada N
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1301-1307. PubMed ID: 29582174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.
    Chawla S; Kim S; Dougherty L; Wang S; Loevner LA; Quon H; Poptani H
    AJR Am J Roentgenol; 2013 Jan; 200(1):35-43. PubMed ID: 23255739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review.
    Bernstein JM; Homer JJ; West CM
    Oral Oncol; 2014 Oct; 50(10):963-70. PubMed ID: 25116700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas.
    Quon H; Brizel DM
    Semin Radiat Oncol; 2012 Jul; 22(3):220-32. PubMed ID: 22687947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers.
    Agrawal S; Awasthi R; Singh A; Haris M; Gupta RK; Rathore RK
    Clin Radiol; 2012 Sep; 67(9):e1-5. PubMed ID: 22583950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning-Based MRI Radiogenomics for Evaluation of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma.
    Li Z; Wang R; Wang L; Tan C; Xu J; Fang J; Xian J
    Acad Radiol; 2024 Jun; 31(6):2464-2475. PubMed ID: 37985290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive population-averaged arterial input function for dynamic contrast-enhanced vmagnetic resonance imaging of head and neck cancer.
    Onxley JD; Yoo DS; Muradyan N; MacFall JR; Brizel DM; Craciunescu OI
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):658-65. PubMed ID: 24929169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy.
    Baghi M; Mack MG; Hambek M; Bisdas S; Muerthel R; Wagenblast J; Gstoettner W; Vogl T; Knecht R
    Head Neck; 2007 Feb; 29(2):104-8. PubMed ID: 17111434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
    Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) for differential diagnosis in head and neck cancers.
    Lee FK; King AD; Ma BB; Yeung DK
    Eur J Radiol; 2012 Apr; 81(4):784-8. PubMed ID: 21376492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI and Doppler sonography in patients with squamous cell carcinoma of head and neck treated with induction chemotherapy.
    Chawla S; Loevner L; Mohan S; Lin A; Sehgal CM; Poptani H
    J Clin Ultrasound; 2022 Nov; 50(9):1353-1359. PubMed ID: 36205388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.